Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.21)
# 2,669
Out of 4,865 analysts
205
Total ratings
40.68%
Success rate
-4.47%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USB U.S. Bancorp | Maintains: In-Line | $44 → $49 | $42.69 | +14.78% | 5 | Jun 4, 2025 | |
| OSUR OraSure Technologies | Maintains: In-Line | $3 | $2.81 | +6.76% | 4 | May 19, 2025 | |
| SYK Stryker | Maintains: Outperform | $400 → $390 | $373.37 | +4.45% | 10 | May 2, 2025 | |
| HOLX Hologic | Maintains: In-Line | $65 → $62 | $64.14 | -3.34% | 14 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $60 → $66 | $52.54 | +25.62% | 4 | May 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $96 → $85 | $71.14 | +19.48% | 4 | May 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $19 → $16 | $11.58 | +33.85% | 8 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $585 → $500 | $390.26 | +28.12% | 11 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $110 → $112 | $101.73 | +10.10% | 6 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $510 → $470 | $512.11 | -8.22% | 12 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $75 → $73 | $73.27 | -0.37% | 11 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,450 → $1,475 | $1,150.57 | +28.20% | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $50 → $52 | $29.31 | +77.41% | 6 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $139.09 | +45.23% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $17.43 | +72.12% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $145 → $142 | $116.09 | +22.32% | 3 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $90.21 | +21.94% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $341.10 | +4.08% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $33.92 | +65.09% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $93.16 | +71.75% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $86.17 | +20.69% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $30.88 | +87.82% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $195.75 | +42.02% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $169.94 | +70.65% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $132.28 | -6.26% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $29.92 | +50.40% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $13.15 | +105.32% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $89.47 | +95.60% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $94.16 | +32.75% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.70 | +899.57% | 1 | May 31, 2022 |
U.S. Bancorp
Jun 4, 2025
Maintains: In-Line
Price Target: $44 → $49
Current: $42.69
Upside: +14.78%
OraSure Technologies
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.81
Upside: +6.76%
Stryker
May 2, 2025
Maintains: Outperform
Price Target: $400 → $390
Current: $373.37
Upside: +4.45%
Hologic
May 2, 2025
Maintains: In-Line
Price Target: $65 → $62
Current: $64.14
Upside: -3.34%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $60 → $66
Current: $52.54
Upside: +25.62%
GE HealthCare Technologies
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $71.14
Upside: +19.48%
Bausch + Lomb
May 1, 2025
Maintains: Outperform
Price Target: $19 → $16
Current: $11.58
Upside: +33.85%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $585 → $500
Current: $390.26
Upside: +28.12%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $101.73
Upside: +10.10%
Intuitive Surgical
Apr 23, 2025
Maintains: In-Line
Price Target: $510 → $470
Current: $512.11
Upside: -8.22%
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $73.27
Upside: -0.37%
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,150.57
Upside: +28.20%
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $29.31
Upside: +77.41%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $139.09
Upside: +45.23%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $17.43
Upside: +72.12%
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $116.09
Upside: +22.32%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $90.21
Upside: +21.94%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $341.10
Upside: +4.08%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $33.92
Upside: +65.09%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $93.16
Upside: +71.75%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $86.17
Upside: +20.69%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $30.88
Upside: +87.82%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $195.75
Upside: +42.02%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $169.94
Upside: +70.65%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $132.28
Upside: -6.26%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $29.92
Upside: +50.40%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $13.15
Upside: +105.32%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $89.47
Upside: +95.60%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $94.16
Upside: +32.75%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.70
Upside: +899.57%